Molecular Screening for Urothelial Cancer: How Close We Are?
Early detection of urothelial cancer offers the potential for effective and successful treatment. Despite previous efforts, currently, there is not a well-validated, recommended screening program in any country. This integrative, literature-based review provides details on how recent molecular advan...
Main Authors: | Athanasios Michas, Basileios Michas, Anastasios Tsitsibis, Nikolaos Tsoukalas |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2023-06-01
|
Series: | Global Medical Genetics |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1768958 |
Similar Items
-
The Clinical Significance of MicroRNAs in Colorectal Cancer Signaling Pathways: A Review
by: Athanasios Michas, et al.
Published: (2023-12-01) -
Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer
by: Pauline A. J. Mendelaar, et al.
Published: (2022-05-01) -
LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer
by: Ming Yang, et al.
Published: (2023-05-01) -
Genomic profiling of Chinese patients with urothelial carcinoma
by: Bo Yang, et al.
Published: (2021-02-01) -
Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial
by: Junlong Wu, et al.
Published: (2024-03-01)